Vinva Investment Management Ltd Buys 1,709 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vinva Investment Management Ltd lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 15.7% in the fourth quarter, HoldingsChannel reports. The fund owned 12,602 shares of the medical equipment provider’s stock after acquiring an additional 1,709 shares during the period. Vinva Investment Management Ltd’s holdings in Intuitive Surgical were worth $4,264,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in shares of Intuitive Surgical by 0.3% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock valued at $3,002,000 after purchasing an additional 27 shares during the period. Sheaff Brock Investment Advisors LLC boosted its position in Intuitive Surgical by 1.3% in the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock valued at $751,000 after buying an additional 29 shares during the period. Liberty Capital Management Inc. increased its position in shares of Intuitive Surgical by 3.8% during the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 30 shares during the period. Miracle Mile Advisors LLC raised its stake in shares of Intuitive Surgical by 2.3% during the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock valued at $485,000 after acquiring an additional 32 shares in the last quarter. Finally, Ausdal Financial Partners Inc. boosted its holdings in shares of Intuitive Surgical by 1.5% in the fourth quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock valued at $739,000 after purchasing an additional 33 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.2 %

Shares of ISRG traded down $0.89 during trading hours on Friday, reaching $417.26. 863,143 shares of the company traded hands, compared to its average volume of 1,521,891. The business has a fifty day moving average price of $388.61 and a 200-day moving average price of $369.52. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $420.57. The stock has a market capitalization of $148.00 billion, a P/E ratio of 75.48, a P/E/G ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same period last year, the firm posted $1.00 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total value of $575,400.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Robert Desantis sold 584 shares of the firm’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $404.41, for a total transaction of $236,175.44. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,226,681.46. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total transaction of $575,400.00. The disclosure for this sale can be found here. Insiders sold 21,687 shares of company stock worth $8,367,952 over the last three months. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on ISRG shares. BTIG Research raised their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. The Goldman Sachs Group assumed coverage on shares of Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 target price on the stock. Finally, Citigroup upped their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $403.67.

View Our Latest Analysis on ISRG

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.